Clinical Trial Details
EORTC-30992
Back to Clinical Trials Database
Phase II study of Irinotecan (CPT 11) and Cisplatin (CDDP) in metastatic or locally advanced penile carcinoma.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 05-Jun-2003 Date Step1 close: 26-Jan-2006 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 28 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00066391 |
| NCT number | NCT00066391 |
